About Oasmia
- Vision & goals
- Research
- Production
- Organization
- Management
- Department Directors
- Board of directors
- History
Board of Directors
The Board of Directors is appointed by the Annual General Meeting and has as its main task to manage the company affairs on behalf of the shareholders. The Board acts in accordance with the Swedish Companies Act, the Articles of Association and internal regulations and continually estimates the Group's financial situation as well as evaluates the management. The Board appoints the CEO and decides if significant changes in the company organization and business need to be made.
The Board of Directors also assures that the company's internal control of the financial development is satisfactory and that information concerning the financial development is correctly communicated in the Company's financial reports.
All Members of the Board except CEO Julian Aleksov are independent with respect to Oasmia and the company management. All Members, except CEO Julian Aleksov and the Chairman Bo Cederstrand are independent with respect to Oasmia's major shareholders. Major shareholders are legal entities or persons controlling more that ten percent of the total number of shares or votes in the company.
Work plan for the Board of Directors
Chairman of the Board since 1999. About 40 years experi-ence as CEO and partner in a number of small and mid-sized businesses, mainly within trade. Extensive experi-ence in international trade and production. Has been very active within trade branch associations. Deputy Member of the Board for the last 5 years in Fruges AB (on-going) and Member of the Board in the Arken stores (ended).
Has an MA in Economics. Member of the Board since 2006. Member of the Board in Active Biotech AB, Chairman of the Board in Periodic AB, Member of the Board in Comtax AB and P.U.L.S AB.
Has an MA in Economics. Member since 2006. Member of the Board in Alfaros AB. Has during the last five years been active as management consultant in, among others, PA Management Consulting and Indevo.
Economist. CEO of Oasmia and one of the founders of the company. Has extensive experience in coordination of research projects and strategic development of global intangible assets. Also Chairman of the Board in Qdoxx Pharma AB and GlucoGene AB.
